Biofrontera Management

Management criteria checks 2/4

Biofrontera's CEO is Hermann Luebbert, appointed in May 2023, has a tenure of 9.17 years. total yearly compensation is $733.23K, comprised of 64.2% salary and 35.8% bonuses, including company stock and options. directly owns 0.21% of the company’s shares, worth $18.69K. The average tenure of the management team and the board of directors is 1.5 years and 2.5 years respectively.

Key information

Hermann Luebbert

Chief executive officer

US$733.2k

Total compensation

CEO salary percentage64.2%
CEO tenureless than a year
CEO ownership0.2%
Management average tenure1.5yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%

Dec 30
Biofrontera Inc. (NASDAQ:BFRI) Not Doing Enough For Some Investors As Its Shares Slump 28%

The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%

Nov 13
The Market Doesn't Like What It Sees From Biofrontera Inc.'s (NASDAQ:BFRI) Revenues Yet As Shares Tumble 43%

Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?

Oct 18
Can Biofrontera (NASDAQ:BFRI) Afford To Invest In Growth?

Biofrontera announces preliminary Q3 product revenue, stock falls ~7% after hours

Oct 05

Biofrontera gets notice of allowance for U.S. patent covering a nanoemulsion formulation

Sep 06

Biofrontera GAAP EPS of -$0.05, revenue of $4.5M; reaffirms FY22 guidance

Aug 12

Biofrontera announces 2Q prelim product revenues

Jul 12

CEO Compensation Analysis

How has Hermann Luebbert's remuneration changed compared to Biofrontera's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$733kUS$471k

-US$20m

Sep 30 2023n/an/a

-US$26m

Jun 30 2023n/an/a

-US$23m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$1mUS$475k

-US$640k

Sep 30 2022n/an/a

-US$12m

Jun 30 2022n/an/a

-US$26m

Mar 31 2022n/an/a

-US$29m

Dec 31 2021US$1mUS$18k

-US$38m

Compensation vs Market: Hermann's total compensation ($USD733.23K) is about average for companies of similar size in the US market ($USD674.55K).

Compensation vs Earnings: Hermann's compensation has been consistent with company performance over the past year.


CEO

Hermann Luebbert (67 yo)

less than a year

Tenure

US$733,225

Compensation

Dr. Prof. Hermann Luebbert, Ph.D. is a Co-Founder of Biofrontera AG and served as its Chief Executive Officer since 1997 until December 13, 2021 and served as its Chairman of Management Board since 2000 un...


Leadership Team

NamePositionTenureCompensationOwnership
Hermann Luebbert
CEO, President & Executive Chairmanless than a yearUS$733.23k0.21%
$ 18.7k
Eugene Leffler
Chief Financial Officer1.6yrsUS$441.68kno data
Erica Gates
Senior Director of Finance & Principal Accounting Officerno datano datano data
Jon Lyons
Vice President of Scientific & Medical Affairs1.3yrsno datano data
Alycia Torres
Vice President of Administration2.3yrsno datano data
Daniel Hakansson
General Counsel & Head of Compliance5.3yrsno datano data
Samantha Widdicombe
Senior Director of Strategic Accounts & Communicationsless than a yearno datano data
Mark Baldyga
Vice President of Sales & Marketingno datano datano data

1.5yrs

Average Tenure

Experienced Management: BFRI's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Hermann Luebbert
CEO, President & Executive Chairman9.2yrsUS$733.23k0.21%
$ 18.7k
John Borer
Independent Director2.5yrsUS$68.64kno data
Heikki Lanckriet
Directorless than a yearUS$19.36kno data
Kevin Weber
Independent Director2.2yrsUS$58.01kno data
Beth Hoffman
Independent Director2.5yrsUS$64.47kno data

2.5yrs

Average Tenure

65yo

Average Age

Experienced Board: BFRI's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.